AKEBIA THERAPEUTICS, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
AKEBIA THERAPEUTICS, INC. (AKBA) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 32.26 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-05
- AKEBIA THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 33.07M shares, a 33.94% increase year-over-year.
- AKEBIA THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 24.69M shares, a 5.13% decline year-over-year.
- AKEBIA THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-09-30 was 25.45M shares, a 34.82% increase year-over-year.
- AKEBIA THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-06-30 was 26.32M shares, a 43.43% increase year-over-year.
- AKEBIA THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 26.59M shares, a 5.56% increase from fiscal 2024.
- AKEBIA THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 25.19M shares, a 45.98% increase from fiscal 2023.
- AKEBIA THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 17.26M shares, a 0.87% decline from fiscal 2022.
- AKEBIA THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 17.41M shares, a 5.02% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 85 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 32.26M shares 10-Q · filed 2026-08-05 | ||||||
| 2026-03-31 | 33.07M shares 10-Q · filed 2026-05-07 | ||||||
| 2025-12-31 | 26.59M shares 10-K · filed 2026-02-26 | ||||||
| 2025-03-31 | 24.69M shares 10-Q · filed 2025-05-08 | ||||||
| 2024-12-31 | 25.19M shares 10-K · filed 2026-02-26 | ||||||
| 2024-09-30 | 25.45M shares 10-Q · filed 2025-11-10 | 25.45M shares 10-Q · filed 2025-11-10 | |||||
| 2024-06-30 | 26.32M shares 10-Q · filed 2025-08-07 | 26.32M shares 10-Q · filed 2025-08-07 | |||||
| 2024-03-31 | 26.02M shares 10-Q · filed 2025-05-08 | 27.18M shares 10-Q · filed 2024-05-09 | |||||
| 2023-12-31 | 17.26M shares 10-K · filed 2026-02-26 | ||||||
| 2023-09-30 | 18.88M shares 10-Q · filed 2024-11-07 | 18.88M shares 10-Q · filed 2024-11-07 | |||||
| 2023-06-30 | 18.35M shares 10-Q · filed 2024-08-08 | 18.35M shares 10-Q · filed 2024-08-08 | |||||
| 2023-03-31 | 20.57M shares 10-Q · filed 2024-05-09 | ||||||
| 2022-12-31 | 17.41M shares 10-K · filed 2024-03-14 | ||||||
| 2022-09-30 | 18.82M shares 10-Q · filed 2023-11-08 | ||||||
| 2022-06-30 | 13.50M shares 10-Q · filed 2023-08-28 | 20.28M shares 10-Q · filed 2023-08-28 | |||||
| 2022-03-31 | 19.97M shares 10-Q · filed 2023-05-08 | ||||||
| 2021-12-31 | 16.57M shares 10-K/A · filed 2023-08-28 | ||||||
| 2021-09-30 | 17.48M shares 10-Q · filed 2022-11-03 | 17.48M shares 10-Q · filed 2021-11-04 | |||||
| 2021-06-30 | 17.62M shares 10-Q · filed 2022-08-04 | 17.62M shares 10-Q · filed 2022-08-04 | |||||
| 2021-03-31 | 18.40M shares 10-Q · filed 2022-05-09 | ||||||
| 2020-12-31 | 14.62M shares 10-K/A · filed 2023-08-28 | ||||||
| 2020-09-30 | 16.16M shares 10-Q · filed 2021-11-04 | ||||||
| 2020-06-30 | 16.54M shares 10-Q · filed 2021-08-05 | ||||||
| 2020-03-31 | 16.62M shares 10-Q · filed 2021-05-10 | ||||||
| 2019-12-31 | 12.70M shares 10-K · filed 2022-03-01 | ||||||
| 2019-09-30 | 13.13M shares 10-Q · filed 2020-11-05 | ||||||
| 2019-06-30 | 10.23M shares 10-Q · filed 2020-08-10 | ||||||
| 2019-03-31 | 12.83M shares 10-Q · filed 2020-05-05 | ||||||
| 2018-12-31 | 9.82M shares 10-K · filed 2021-02-25 | ||||||
| 2018-09-30 | 5.36M shares 10-Q · filed 2019-11-12 | ||||||
| 2018-06-30 | 5.49M shares 10-Q · filed 2018-08-08 | ||||||
| 2018-03-31 | 5.49M shares 10-Q · filed 2019-08-08 | 5.53M shares 10-Q · filed 2018-05-09 | |||||
| 2017-12-31 | 4.90M shares 10-K · filed 2020-03-12 | ||||||
| 2017-09-30 | 5.00M shares 10-Q · filed 2018-11-08 | ||||||
| 2017-06-30 | 5.39M shares 10-Q · filed 2017-08-08 | 5.39M shares 10-Q · filed 2018-08-08 | |||||
| 2017-03-31 | 5.27M shares 10-Q · filed 2018-05-09 | ||||||
| 2016-12-31 | 3.67M shares 10-K · filed 2019-03-26 | ||||||
| 2016-09-30 | 3.55M shares 10-Q · filed 2016-11-09 | 3.55M shares 10-Q · filed 2017-11-08 | |||||
| 2016-06-30 | 3.31M shares 10-Q · filed 2017-08-08 | 3.31M shares 10-Q · filed 2017-08-08 | |||||
| 2016-03-31 | 3.30M shares 10-Q · filed 2017-05-09 | ||||||
| 2015-12-31 | 2.45M shares 10-K · filed 2018-03-12 | ||||||
| 2015-09-30 | 2.54M shares 10-Q · filed 2016-11-09 | 2.54M shares 10-Q · filed 2016-11-09 | |||||
| 2015-06-30 | 2.30M shares 10-Q · filed 2016-08-08 | 2.30M shares 10-Q · filed 2016-08-08 | 2.30M shares 10-Q · filed 2015-08-11 | ||||
| 2015-03-31 | 2.31M shares 10-Q · filed 2016-05-05 | ||||||
| 2014-12-31 | 1.95M shares 10-K · filed 2017-03-06 | ||||||
| 2014-09-30 | 2.16M shares 10-Q · filed 2015-11-09 | 2.16M shares 10-Q · filed 2015-11-09 | |||||
| 2014-06-30 | 1.99M shares 10-Q · filed 2015-08-11 | 1.99M shares 10-Q · filed 2015-08-11 | |||||
| 2014-03-31 | 1.83M shares 10-Q · filed 2015-05-11 | 1.83M shares 10-Q · filed 2014-05-12 | |||||
| 2013-12-31 | 13.88M shares 10-K · filed 2015-03-04 | ||||||
| 2013-09-30 | 13.22M shares 10-Q · filed 2014-11-10 | 13.22M shares 10-Q · filed 2014-11-10 | |||||
| 2013-06-30 | 12.40M shares 10-Q · filed 2014-08-11 | 12.40M shares 10-Q · filed 2014-08-11 | |||||
| 2013-03-31 | 7.17M shares 10-Q · filed 2014-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |